The investment will make the Indianapolis facility the hub for manufacturing of Roche’s continuous glucose monitoring system.

The investment, which is expected to be complete by 2030, will boost U.S. production of Roche’s continuous glucose monitoring ...

Roche Diagnostics plans to produce glucose monitors at the site within three years and prepare for future generations of its ...

Roche announced today that it plans to invest up to $550 million to expand its continuous glucose monitoring (CGM) site in ...

Officials with Roche Diagnostics announced on Monday that it will invest $550 million in its Indianapolis site by 2030.

mySugr's aim is to 'make diabetes suck less' through the use ... Since then, the pair have partnered to combine data from Roche's Accu-Chek Connect blood glucose meter into the mySugr app.

A digital health application (DiGA) has been shown to relieve the distress that patients can experience when managing diabetes ... alongside products like its Accu-Chek blood glucose testing ...

It houses research and development, laboratories, manufacturing and other functions, and produces Roche’s Accu-Chek diabetes test strips. The facility is one of two global distribution hubs for ...

INDIANAPOLIS — Roche has announced plans to invest up to $550 million in its Diagnostics facility in Indianapolis by 2030.